| NCT05293171 | Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects | COMPLETED | PHASE1 | 2021-06-11 | 2022-08-15 | 2022-06-01 |
| NCT03246529 | A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM) | ACTIVE_NOT_RECRUITING | PHASE3 | 2018-03-23 | 2029-09-30 | 2020-12-22 |
| NCT03154827 | Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML) | TERMINATED | PHASE1, PHASE2 | 2018-01-08 | 2020-04-01 | 2020-04-01 |
| NCT02826486 | Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients | COMPLETED | PHASE2 | 2016-09 | 2022-09-06 | 2022-09-06 |
| NCT02462252 | Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome | COMPLETED | PHASE2 | 2015-10 | 2020-11 | 2020-11 |
| NCT02073019 | A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers | COMPLETED | PHASE1 | 2014-08 | 2015-07 | 2015-07 |
| NCT01990885 | Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. | COMPLETED | PHASE1, PHASE2 | 2013-12 | 2014-10 | 2014-10 |
| NCT01838395 | Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients | COMPLETED | PHASE2 | 2013-04 | 2023-07-20 | 2016-03 |
| NCT01833845 | Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C | TERMINATED | PHASE1, PHASE2 | 2013-04 | 2014-04 | 2014-04 |
| NCT01506362 | Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis | COMPLETED | PHASE2 | 2012-03 | 2013-05 | 2013-05 |
| NCT01121380 | A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021 | TERMINATED | PHASE1 | 2011-06 | 2011-10 | 2011-10 |
| NCT01363349 | Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia | TERMINATED | PHASE2, PHASE3 | 2011-05 | 2013-04 | 2013-03 |
| NCT00567710 | A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study | COMPLETED | PHASE2 | 2008-07 | 2009-09 | 2009-07 |
| NCT00722176 | Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 | COMPLETED | PHASE2 | 2008-06 | 2009-12 | 2009-07 |
| NCT00557531 | Safety and Feasibility of the Injectable BL-1040 Implant | UNKNOWN | PHASE1, PHASE2 | 2008-03 | 2014-01 | 2010-01 |
| NCT00480571 | Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder | COMPLETED | PHASE2 | 2007-06 | 2007-12 | 2007-12 |
| NCT00480246 | A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer | COMPLETED | PHASE1 | 2007-05 | | |
| NCT00374881 | A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects | COMPLETED | PHASE1, PHASE2 | 2006-09 | 2007-08 | 2007-06 |